Interferon-gamma (IFN-γ) measured in an IGRA test helps detect tuberculosis infection by assessing immune cell response to TB-specific antigens.
Interferon-gamma is often considered in the context of tiredness, reduced capacity, brain fog, or chronic exhaustion. This short overview clarifies what the marker can contribute, where its limits are, and when symptom or illness context becomes more important.
Interferon-gamma becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
Interferon-gamma does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
Interferon-gamma (IFN-γ) is a cytokine produced by T-cells and natural killer cells, crucial for coordinating the immune response against intracellular pathogens. In an Interferon-Gamma Release Assay (IGRA), your blood is exposed to antigens from Mycobacterium tuberculosis; if your immune system has encountered TB, sensitized T-cells release IFN-γ, which is then measured. This test aids in screening for latent or active tuberculosis infection and is often used as an alternative to the tuberculin skin test.
A low Interferon-gamma result (usually below 0.35 IU/mL, lab-dependent) is considered negative, suggesting no TB infection. Very low or undetectable levels are typical in healthy individuals without TB exposure. However, a false-negative result can occur if the immune system is compromised (e.g., due to immunosuppression, advanced age, or certain medications), so clinical context is essential.
An elevated Interferon-gamma level above the cutoff (e.g., ≥0.35 IU/mL, lab-dependent) suggests TB infection, either latent or active. High values may also result from infection with certain nontuberculous mycobacteria or, rarely, from assay-related factors. A positive IGRA does not distinguish between latent and active TB, so further evaluation—such as chest imaging and microbiological tests—is typically required.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Interferon-gamma becomes relevant when low-grade inflammation, immune activity, or recovery questions are part of the picture. It can help flag inflammatory context, but it does not map symptom severity on its own.
An IGRA (Interferon-Gamma Release Assay) is a blood test that measures IFN-γ released by your immune cells when exposed to TB-specific antigens. Unlike the TB skin test (TST), it requires only one visit, is not affected by previous BCG vaccination, and results are less subjective. Both tests help identify latent TB infection, but IGRAs are often preferred in BCG-vaccinated populations.
If fatigue persists, exertion is tolerated poorly, or symptoms escalate after activity, the marker should be linked to a broader fatigue, ME/CFS, PEM, or questionnaire context. That usually makes interpretation far more useful than treating the value as a standalone endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Interferon-gamma (IGRA test) alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
A positive IGRA (IFN-γ above the lab-specific cutoff, often ≥0.35 IU/mL) means your immune cells have likely encountered Mycobacterium tuberculosis. It indicates latent TB infection (you carry the bacteria without symptoms) or active TB disease. Additional tests, like a chest X-ray and symptom assessment, are needed to determine the stage and guide treatment.
Yes, a false-negative can occur if your immune system is unable to produce enough IFN-γ, for example, due to HIV infection, immunosuppressive drugs, severe illness, or in very young or elderly individuals. Also, testing too soon after TB exposure (before the immune response develops) may lead to a negative result. If TB is strongly suspected, alternative diagnostics may be used.
Interferon-gamma does not explain PEM, delayed worsening after activity, unstable day-to-day function, or a wider multisystem pattern on its own. A single lab value can support interpretation, but it cannot replace symptom timing and longitudinal context.
For many fatigue-related, inflammatory, hormonal, or recovery-linked markers, interpretation becomes stronger when symptoms, exertion response, and daily function are considered together.
Interferon-gamma is rarely meaningful in isolation when fatigue, brain fog, or unstable capacity are central. The fatigue hub provides the broader lab-and-symptom context.
If symptoms worsen after activity with a delay, PEM often explains more than an isolated lab value alone.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.
